Department of Insurance, Securities and Banking

DC Agency Top Menu

The Department is currently conducting business via telework and will not be able to address consumer issues in person. Read more >> 
Phase Two of Reopening Set to Begin on June 22

-A +A
Bookmark and Share

New DISB Guides Help Consumers Compare Prescription Costs for HIV/AIDs, Cancer and Diabetes Treatments

Monday, April 25, 2016
New “Rx Review Guides” create transparency for out-of-pocket drug costs for plans sold on DC Health Link.

The District of Columbia Department of Insurance, Securities and Banking (DISB) published three guides to help consumers compare the out-of-pocket costs for commonly prescribed drugs that treat HIV/AIDs, cancer and diabetes.

Insurance companies divide prescription drugs into tiers based on varying levels of cost and each insurance company uses different language to explain its drug tiering. The guides provide a reference consumers can use alongside the health plan's Summary of Benefits and Coverage to compare out-of-pocket prescription costs.

“If you or a family member covered under your health plan has one of these health conditions, knowing the cost of medications can help you make a more informed decision during plan selection,” said Commissioner Stephen C. Taylor. “Our new guides help create transparency in the marketplace by allowing consumers to compare out-of-pocket prescription expenses.”

To view the Rx guides, follow the links below. If you have any questions about the new DISB Rx Guides, please contact DISB's Insurance Bureau at (202) 727-8000.